2010 to 2021 Saw Increase in Incidence of Stage IV Breast Cancer

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 27, 2026.

via HealthDay

WEDNESDAY, May 27, 2026 -- From 2010 to 2021, there was a significant increase in the incidence of stage IV breast cancer, according to a study published online May 12 in JAMA Network Open.

Jorge Avila, M.D., from the Montefiore Medical Center in Bronx, New York, and colleagues examined incidence, percentage, and survival of people with de novo stage IV breast cancer diagnosed from 2010 through 2021 in a population-based cohort study.

The researchers observed an increase in stage IV incidence, from 9.5 to 11.2 cases per 100,000 women in 2010 and 2021, respectively (annual percentage change [APC], 1.2 percent). There was also an increase in the incidence of stages I to III disease, from 163.0 to 177.4 cases per 100,000 women in 2010 and 2021, respectively. An increase was seen in stage IV incidence across all tumor subtypes, with APCs of 2.0, 1.6, 1.3, and 2.7 percent for hormone receptor (HR)-positive/ERBB2-negative, HR-positive/ERBB2-positive, HR-negative/ERBB2-positive, and triple-negative disease, respectively. The incidence of stage IV disease increased significantly across all age groups and numerically across all racial groups. A significant increase was seen in stage IV incidence among men, with an APC of 3.7 percent. In each tumor subgroup, the percentage of stage IV diagnoses increased significantly from 2010 to 2021.

"This study raises concern because we don't have good answers as to why we are seeing an increase in de novo metastatic breast cancer, regardless of breast cancer subtype," senior author José P. Leone, M.D., from Harvard Medical School in Boston, said in a statement.

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords